With just a drop of the mother's blood, it may soon be possible to determine whether an unborn baby has a genetic disorder, say researchers.
The scientists hope that soon a simple blood test would help determine if the fetus has a disorder such as cystic fibrosis or beta-thalassaemia.
Birth Defects - Genetic - Cystic Fibrosis
Cystic fibrosis is a progressively debilitating genetic disorder, which mainly affects the lungs and the digestive system
Advertisement
The conventional methods involve tests such as amniocentesis, in which a sample of amniotic fluid surrounding the fetus is taken; however, it increases the risk of suffering a miscarriage.
The researchers said that the blood of a pregnant woman contains DNA from both herself and from her fetus. This genetic material can be removed from a blood sample and screened for disease genes.
![Respiratory Diseases - Cystic Fibrosis]( "Respiratory Diseases - Cystic Fibrosis")
Encyclopedia section of medindia gives general info about Cystic Fibrosis
It may be possible to detect errors in a single gene by taking blood from the mother and counting the ratio of mutations to normal genes.
With the help of a technique called digital polymerase chain reaction, (dPCR), the researchers were able to count copies of the gene for beta-thalassaemia in blood samples from pregnant women.
By noting ratios of recessive genes relative to normal copies of the gene, the researchers were able to work out if the fetus would develop the disease.
"We believe that the large proportion of invasive prenatal tests will one day be replaced," New Scientist quoted Lead researcher Dennis Lo of the Chinese University of Hong Kong, as saying.
"This [new] test saves those babies who would be incidentally aborted by invasive testing," he added.
The study appears in Proceedings of the National Academies of Science.
Source: ANI
SRM
Respiratory Diseases - Cystic Fibrosis
Encyclopedia section of medindia gives general info about Cystic Fibrosis
Advertisement
It may be possible to detect errors in a single gene by taking blood from the mother and counting the ratio of mutations to normal genes.
With the help of a technique called digital polymerase chain reaction, (dPCR), the researchers were able to count copies of the gene for beta-thalassaemia in blood samples from pregnant women.
By noting ratios of recessive genes relative to normal copies of the gene, the researchers were able to work out if the fetus would develop the disease.
"We believe that the large proportion of invasive prenatal tests will one day be replaced," New Scientist quoted Lead researcher Dennis Lo of the Chinese University of Hong Kong, as saying.
"This [new] test saves those babies who would be incidentally aborted by invasive testing," he added.
The study appears in Proceedings of the National Academies of Science.
Source: ANI
SRM
Electronic Fetal Monitoring - Animation
Fetal monitoring records the condition of the fetus and contractions of the uterus during the labour
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest General Health News
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.